Fibrinogen-induced endothelin-1 production from endothelial cells

American Journal of Physiology - Cell Physiology

Volumn 296, Issue 4, 2009, Pages

  Sen, Utpal ^a   Tyagi, Neetu ^a   Patibandla, Phani K ^a   Dean, William L ^a   Tyagi, Suresh C ^a   Roberts, Andrew M ^a   Lominadze, David ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Exocytosis; Extracellular signal regulated kinase; Intercellular adhesion molecule 1; Von Willebrand factor; Weibel Palade bodies

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME INHIBITOR; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; VON WILLEBRAND FACTOR;

ARTERY CONSTRICTION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; FIBRIN FORMATION; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; WEIBEL PALADE BODY; WESTERN BLOTTING;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BUTADIENES; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIN-1; EXOCYTOSIS; FIBRINOGEN; FLAVONOIDS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; METALLOENDOPEPTIDASES; MICROVESSELS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; OLIGOPEPTIDES; PHOSPHORYLATION; PIPERIDINES; PROTEIN KINASE INHIBITORS; RATS; RECEPTOR, ENDOTHELIN B; SULFONAMIDES; SULFONYLUREA COMPOUNDS; VASOCONSTRICTION; VON WILLEBRAND FACTOR; WEIBEL-PALADE BODIES;

RATTUS;

EID: 65649130114     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00515.2008     Document Type: Article

References (55)

1. Belkin AM, Tsurupa G, Zemskov E, Veklich Y, Weisel JW, Medved L. Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling. Blood 105: 3561-3568, 2005. (Pubitemid 40628201)
2. Bennett J. Platelet-fibrinogen interactions. Ann NY Acad Sci 936: 340-354, 2001. (Pubitemid 32613920)
3. Bots ML, Elwood PC, Salonen JT, Freire de Concalves A, Sivenius J, Di Carlo A, Nikitin Y, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 56: i14-i18, 2002. (Pubitemid 34098450)
4. Boyd J, Chau E, Tokunanga C, Bateman R, Haljan G, Davani E, Wang Y, Walley K. Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism. Crit Care 12: R2, 2008.
5. Brunner E, Davey Smith G, Marmot M, Canner R, Beksinska M, O'Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma. Lancet 347: 1008-1013, 1996. (Pubitemid 26112174)
6. Deng LY, Li JS, Schiffrin EL. Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc Res 29: 532-535, 1995.
7. Engström G, Hedblad B, Tydén P, Indgärde F. Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis 202: 617-622, 2009.
8. Fornoni A, Ijaz A, Tejada T, Lenz O. Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 4: 10-17, 2008.
9. Gardiner EE, D'Souza SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 272: 15474-15480, 1997.
10. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206, 2003. (Pubitemid 37487347)
11. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
12. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14: 54-59, 1994. (Pubitemid 24028168)
13. Juan S, Chen J, Chen C, Lin H, Cheng C, Liu J, Hsieh M, Chen Y, Chao H, Chen T, Chan P, Cheng T. 17β-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287: H1254-H1261, 2004. (Pubitemid 39096674)
14. A receptors. Am J Physiol Renal Physiol 286: F660-F668, 2004.
15. Kannel WB, D'Agostino RB, Belanger AJ, Silbershatz H, Tofler GT. Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women. Am J Cardiol 78: 90-92, 1996. (Pubitemid 26255458)
16. Kim B, Kim J, Bae YM, Cho SI, Kwon SC, Jung JY, Park J, Ahn HY. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension 43: 1086-1091, 2004. (Pubitemid 38579918)
17. Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT. Fibrinogen is a marker for nephropathy and peripheral vascular disease in Type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care 26: 1439-1448, 2003. (Pubitemid 36929176)
18. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89: 601-609, 2003. (Pubitemid 36456957)
19. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273-278, 1990. (Pubitemid 20105760)
20. Languino L, Plescia J, Duperrray A, Brian A, Plow E, Geltosky J, Alteri D. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73: 1423-1434, 1993. (Pubitemid 23201154)
21. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 92: 1505-1509, 1995.
22. Levin E. Endothelins. N Engl J Med 333: 356-363, 1995.
23. Li Z, Theus M, Wei L. Role of ERK 1/2 signaling in neuronal differentiation of cultured embryonic stem cells. Dev Growth Differ 46: 513-523, 2006. (Pubitemid 44506857)
24. Lincoln DW, Larsen AM, Phillips PG, Bove K. Isolation of murine aortic endothelial cells in culture and the effects of sex steroids on their growth. In Vitro Cell Dev Biol Anim 39: 140-145, 2003. (Pubitemid 37204097)
25. Lominadze D, Schuschke D, Joshua I, Dean W. Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats. Clin Exp Hypertens 24: 397-406, 2002. (Pubitemid 34743402)
26. Lominadze D, Tsakadze N, Sen U, Falcone J, D'Souza S. Fibrinogen- and fragment D-induced vascular constriction. Am J Physiol Heart Circ Physiol 288: H1257-H1264, 2005. (Pubitemid 40270032)
27. Lowe GDO. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3: 1618-1627, 2005.
28. Lowe G, Rumley A. Fibrinogen and its degradation products as thrombotic risk factors. Ann NY Acad Sci 936: 560-565, 2001. (Pubitemid 32613942)
29. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem 13: 1655-1665, 2006. (Pubitemid 43821697)
30. Matsumura Y, Kuro T, Obayashi Y, Ekawa K, Hashi N, Akaoka M. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats. Jpn J Pharmacol 84: 16-24, 2000.
31. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312: 1061-1065, 1996. (Pubitemid 26125131)
32. Mogford J, Davis G, Meininger G. RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelial-dependent vasoconstriction to rat skeletal muscle arterioles. J Clin Invest 100: 1647-1653, 1997. (Pubitemid 27425793)
33. Morey A, Razandi M, Pedram A, Hu R, Prins B, Levin E. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 15: 1097-1105, 1998. (Pubitemid 28161982)
34. Nakamura S, Naruse M, Naruse K, Demura H, Uemura H. Immunocytochemical localization of endothelin in cultured bovine endothelial cells. Histochemistry 94: 475-477, 1990. (Pubitemid 20303240)
35. Nishimura J, Aoki H, Chen X, Shikasho T, Kobayashi S, Kanaide H. Evidence for the presence of endothelin ETA receptors in endothelial cells in situ on the aortic side of porcine aortic valve. Br J Pharmacol 115: 1369-1376, 1995.
36. Pluskota E, D'Souza S. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur J Biochem 267: 4693-4704, 2000. (Pubitemid 30619459)
37. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 26: 1002-1007, 2006. (Pubitemid 43732104)
38. Russell F, Skepper J, Davenport A. Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol 31: 424-430, 1998. (Pubitemid 28103623)
39. Russell F, Skepper J, Davenport A. Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83: 314-321, 1998. (Pubitemid 28371321)
40. Schiffrin E, Lariviere R, Touyz R. ETA and ETB receptors on vascular smooth muscle cells from mesenteric vessels of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22: S193-S194, 1995. (Pubitemid 26062077)
41. Sen U, Moshal K, Tyagi N, Kartha G, Tyagi S. Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells. J Cell Physiol 209: 767-774, 2006. (Pubitemid 44665699)
42. Sen U, Tyagi N, Kumar M, Moshal KS, Rodriguez WE, Tyagi SC. Cystathionine-β-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am J Physiol Cell Physiol 293: C1779-C1787, 2007. (Pubitemid 350255073)
43. Soria JM, Almasy L, Souto JC, Buil A, Lathrop M, Blangero J, Fontcuberta J. A genome search for genetic determinants that influence plasma fibrinogen levels. Arterioscler Thromb Vasc Biol 25: 1287-1292, 2005. (Pubitemid 40776623)
44. Springer T. Adhesion receptors of the immune system. Nature 346: 425-434, 1990. (Pubitemid 20251059)
45. Sturgeon JD, Folsom AR, Longstreth W Jr, Shahar E, Rosamond WD, Cushman M. Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke 39: 2268-2273, 2008.
46. Touyz RM. Recent advances in intracellular signalling in hypertension. Curr Opin Nephrol Hypertens 12: 165-174, 2003.
47. Touyz R. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90: 449-455, 2005. (Pubitemid 40980144)
48. Tyagi N, Roberts A, Dean W, Tyagi S, Lominadze D. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 307: 13-22, 2008. (Pubitemid 350238642)
49. Vischer U, Wagner D. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82: 1184-1191, 1993. (Pubitemid 23253992)
50. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068, 1992.
51. Waki H, Liu B, Miyake M, Katahira K, Murphy D, Kasparov S, Paton JFR. Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension 49: 1321-1327, 2007. (Pubitemid 46809375)
52. Wong LYF, Leung RYH, Ong KL, Cheung BMY. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension. J Hum Hypertens 21: 875-882, 2007.
53. Yamazaki T, Seko Y, Tamatani T, Miyasaka M, Yagita H, Okumura K, Nagai R, Yazaki Y. Expression of intercellular adhesion molecule-1 in rat heart with ischemia-reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol 143: 410-418, 1993. (Pubitemid 24058196)
54. Yogi A, Callera G, Montezano A, Aranha A, Tostes R, Schiffrin E, Touyz R. Endothelin-1, but not Ang II, activates MAP kinases through c-Src-independent Ras-Raf-dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27: 1960-1967, 2007. (Pubitemid 47312305)
55. Zhao H, Joshua I, Porter J. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 13: 819-826, 2000. (Pubitemid 30604121)